Menu

ESMO 2025 – iza-bren’s US backing comes with toxicity | ApexOnco - Clinical Trials news and analysis

Article |

infomaker03 7mo ago
ESMO 2025 – iza-bren’s US backing comes with toxicity | ApexOnco - Clinical Trials news and analysis

Bristol stated that “haematologic adverse events were effectively managed by standard medical measures”. The trial, described as iza-bren's...

Comments (0)

Newest

No comments yet.